Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

NCT00005988

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +47 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Minnesota Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)

NCT00732641

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

NCT02129569

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

NCT01626547

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy-induced Symptomatic Anaemia, +17 more
Locations: Alzey, Germany

Bad Säckigen, Germany

Berlin, Germany

Berlin, Germany

View all 39 locations

View Trial Details

Completed

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

NCT00259740

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Completed

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

NCT00577642

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Multi-day Doses in Prevention of Nausea and Emesis

NCT00600353

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

NCT00143845

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations: Stanford University Palo Alto, California, United States

Norwestern Memorial Hospital Chicago, Illinois, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions